PSSD: Difference between revisions

From Long Haul Wiki
Jump to navigation Jump to search
Line 33: Line 33:
** Suicidal ideation
** Suicidal ideation
** Lower self-esteem and lack of pleasure
** Lower self-esteem and lack of pleasure
=== Sheetrit et al. ===
''Post-SSRI Sexual Dysfunction; Clinical Characterization and Preliminary Assessment of Contributory Factors and Dose-Realted Relationship'' by Joseph Ben-Sheetrit et. al Journal of Clin Pharm, 06/2015. DOI:[https://doi.org/10.1097/JCP.0000000000000300 10.1097/JCP.0000000000000300]
The paper is available [https://drive.google.com/file/d/1EPkBcEPh6g8OeAprMurZgSrF_om-hIU7/view?usp=sharing here].

Revision as of 20:38, 31 May 2023

Post-SSRI sexual dysfunction

Research

Bubzoluck-PSSD.png

u/Bubzoluck (PharmD)

The Reddit user Bubzoluck has posted results of his/her PSSD survey. Findings include:

  • Two thirds were male. 80 responses received.
  • Young demographic. (It is unclear if this is a reflection of the Reddit demographic?)
  • Most people were on their PSSD med for less than a year
  • Most people reported having PSSD for >1 year since stopping their med
  • SSRIs were the most common cause of PSSD (82.5%). 3 medications were the most common- Zoloft/sertraline (30%), Lexapro/escitalopram (20%), and Prozac/fluoxetine (12%).

Core symptoms were:

  • Sexual Symptoms
    • Difficulty generating or sustaining an erection
    • Reduced genital sensation
    • Pleasureless or weak orgasms
    • Reduced response to sex stimuli
    • Vaginal dryness
  • Cognitive Symptoms
    • Difficulty concentrating
    • Short an/or long term memory impairment
    • Loss of creativity and visualization inside mind
    • Speaking, reading, writing, solving slower
    • Difficulty understanding information
  • Mood Symptoms
    • Depression and low moods
    • Feelings of emptiness or helplessness
    • Loss of energy and insomnia
    • Suicidal ideation
    • Lower self-esteem and lack of pleasure

Sheetrit et al.

Post-SSRI Sexual Dysfunction; Clinical Characterization and Preliminary Assessment of Contributory Factors and Dose-Realted Relationship by Joseph Ben-Sheetrit et. al Journal of Clin Pharm, 06/2015. DOI:10.1097/JCP.0000000000000300

The paper is available here.